Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (30)
NITAG documentation (1591)
Reports (55)
SAGE documentation (218)
Scientific publications (112)
Systematic reviews (SYSVAC) (2750)
Regions
Africa (267)
Americas (762)
Eastern Mediterranean (48)
Europe (704)
South-East Asia (78)
Western Pacific (196)
Diseases
Chikungunya (9)
Cholera (33)
COVID-19 (1481)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4756 results found
2016
∙
Wayne Hachey
Improved Efficacy of Recombinant Influenza Vaccine vs. Inactivated Vaccine During an Influenza Season Marked by a Vaccine Mismatch
2016
∙
Lynnette Brammer
Influenza Epidemiology and Surveillance Update
2016
∙
Brendan Flannery, Jessie Chung
Influenza Vaccine Effectiveness, Including LAIV vs IIV in Children and Adolescents, US Flu VE Network, 2015-16
2016
∙
JCVI
JCVI statement on the use of nasal spray flu vaccine for the childhood influenza immunisation programme
2016
∙
Susan Hills
JE Vaccine Workgroup Summary and Plans
2016
∙
Olen M Kew
Laboratory Containment of Poliovirus in the United States Phase II (Poliovirus Type 2): Update
2016
∙
Brendan Flannery
LAIV vs IIV effectiveness Summary of evidence since 2009
2016
∙
WHO
Meeting of the Strategic Advisory Group of Experts on immunization, April 2016– conclusions and recommendations
2016
∙
SAGE
Meeting of the Strategic Advisory Group of Experts on immunization, October 2016 – conclusions and recommendations
2016
∙
Temitope Folaranmi
Meningococcal Disease Among Men Who Have Sex with Men – United States, January 2012 - June 2015
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register